178 related articles for article (PubMed ID: 37996458)
1. ID1 expressing macrophages support cancer cell stemness and limit CD8
Shang S; Yang C; Chen F; Xiang RS; Zhang H; Dai SY; Liu J; Lv XX; Zhang C; Liu XT; Zhang Q; Lu SB; Song JW; Yu JJ; Zhou JC; Zhang XW; Cui B; Li PP; Zhu ST; Zhang HZ; Hua F
Nat Commun; 2023 Nov; 14(1):7661. PubMed ID: 37996458
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic β-catenin signaling suppresses CD8
Xue J; Yu X; Xue L; Ge X; Zhao W; Peng W
Biomed Pharmacother; 2019 Jul; 115():108921. PubMed ID: 31078045
[TBL] [Abstract][Full Text] [Related]
3. Blockade of DC-SIGN
Hu B; Wang Z; Zeng H; Qi Y; Chen Y; Wang T; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J
Cancer Res; 2020 Apr; 80(8):1707-1719. PubMed ID: 32060149
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor of DNA binding 1 (Id1) mediates stemness of colorectal cancer cells through the Id1-c-Myc-PLAC8 axis via the Wnt/β-catenin and Shh signaling pathways.
Sun Y; Lai X; Yu Y; Li J; Cao L; Lin W; Huang C; Liao J; Chen W; Li C; Yang C; Ying M; Chen Q; Ye Y
Cancer Manag Res; 2019; 11():6855-6869. PubMed ID: 31440083
[TBL] [Abstract][Full Text] [Related]
5. Targeting CD43 optimizes cancer immunotherapy through reinvigorating antitumor immune response in colorectal cancer.
Li YY; Wang XY; Li Y; Wang XM; Liao J; Wang YZ; Hong H; Yi W; Chen J
Cell Oncol (Dordr); 2023 Jun; 46(3):777-791. PubMed ID: 36920728
[TBL] [Abstract][Full Text] [Related]
6. STAT3-Mediated Promoter-Enhancer Interaction Up-Regulates Inhibitor of DNA Binding 1 (
Lin Z; Liu Y; Xu T; Su T; Yang Y; Liang R; Gu S; Li J; Song X; Liang B; Leng Z; Li Y; Meng L; Luo Y; Chang X; Huang D; Xie L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373188
[TBL] [Abstract][Full Text] [Related]
7. Blocking LTB
Yan J; Zhu J; Li X; Yang R; Xiao W; Huang C; Zheng C
Phytomedicine; 2023 Oct; 119():154968. PubMed ID: 37531900
[TBL] [Abstract][Full Text] [Related]
8. Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade.
Song M; Qian C; Zhang T; Tang Y; Zhou Y; Wei Z; Wang A; Zhong C; Zhao Y; Lu Y
J Ethnopharmacol; 2023 Nov; 316():116735. PubMed ID: 37286115
[TBL] [Abstract][Full Text] [Related]
9. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
[TBL] [Abstract][Full Text] [Related]
10. CCL5-deficiency enhances intratumoral infiltration of CD8
Zhang S; Zhong M; Wang C; Xu Y; Gao WQ; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):766. PubMed ID: 29991744
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
12. Tumor-derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer.
Shi W; Zhang F; Chen X; Wang S; Zhang H; Yang Z; Wang G; Zheng Y; Han Y; Sun Y; Gao A
Cancer Sci; 2022 Jun; 113(6):1939-1954. PubMed ID: 35377522
[TBL] [Abstract][Full Text] [Related]
13. CXCL8 induces M2 macrophage polarization and inhibits CD8
Shao Y; Lan Y; Chai X; Gao S; Zheng J; Huang R; Shi Y; Xiang Y; Guo H; Xi Y; Yang L; Yang T
FASEB J; 2023 Oct; 37(10):e23173. PubMed ID: 37665572
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis.
Lv Y; Tang W; Xu Y; Chang W; Zhang Z; Lin Q; Ji M; Feng Q; He G; Xu J
Int J Biol Sci; 2023; 19(4):1284-1298. PubMed ID: 36923931
[No Abstract] [Full Text] [Related]
15. The Agpat4/LPA axis in colorectal cancer cells regulates antitumor responses via p38/p65 signaling in macrophages.
Zhang D; Shi R; Xiang W; Kang X; Tang B; Li C; Gao L; Zhang X; Zhang L; Dai R; Miao H
Signal Transduct Target Ther; 2020 Mar; 5(1):24. PubMed ID: 32296017
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
[TBL] [Abstract][Full Text] [Related]
17. YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8
Ma S; Sun B; Duan S; Han J; Barr T; Zhang J; Bissonnette MB; Kortylewski M; He C; Chen J; Caligiuri MA; Yu J
Nat Immunol; 2023 Feb; 24(2):255-266. PubMed ID: 36658237
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy.
Thankamony AP; Murali R; Karthikeyan N; Varghese BA; Teo WS; McFarland A; Roden DL; Holliday H; Konrad CV; Cazet A; Dodson E; Yang J; Baker LA; George JT; Levine H; Jolly MK; Swarbrick A; Nair R
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32911668
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis.
Fang H; Huang Y; Luo Y; Tang J; Yu M; Zhang Y; Zhong M
Cell Immunol; 2022 Jan; 371():104458. PubMed ID: 34847407
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Notch activation is advantageous but not essential for T cell lymphomagenesis in Id1 transgenic mice.
Wang HC; Peng V; Zhao Y; Sun XH
PLoS One; 2012; 7(2):e32944. PubMed ID: 22393458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]